Abstract :

Objective: To describe the association of clinical characteristics, clinical progression, and outcome of COVID-19 patients in TAK province, Thailand
Methods: This retrospective cohort study included patients who were diagnosed with COVID-19 in Tak province, Thailand from June 1, 2021 to December 31, 2021.
Results: The statistical analysis was done on the records of 15,442 patients who underwent RT-PCR of SARS-CoV-2 detection at Tak province during the fourth wave of the outbreak. 53.9% of patients were diagnosed asymptomatic. The overall mortality rate among patients with COVID-19 in this study was 1.81%. Patients with ages over 60 years was associated with increased risk of pneumonia (aOR 5.16, 95% CI 4.52-5.89; P < 0.001) and death (aOR 22.09, 95% CI 12.66-38.53, P < 0.001). Myanmar were also significantly associated with pneumonia (aOR 1.15, 95% CI 1.00-1.33, P < 0.001) and death (aOR 1.99, 95% CI 1.44-2.78, P < 0.001). Chronic Kidney Disease (aOR 3.84, 95% CI 2.31-6.38, P < 0.001) and dyspnea (aOR 4.54, 95% CI 3.27-6.31, P < 0.001) were associated with increased odds of death as well as the presence of more than one comorbidity (aOR 2.87, 95% CI 1.99-4.14, P < 0.001). The previous receipt of vaccination regardless of partially (aOR 0.14, 95% CI 0.08-0 .27; P < 0.001) or fully vaccination (aOR 0.08, 95% CI 0.03-0.19; P < 0.001) was associated with lower odds of mortality. Conclusions: Determining high-risk COVID-19 infected patients can help in the design of appropriate measures and proper management strategies. Ongoing mass vaccination efforts is still an absolutely priority for Thai and non-Thai citizens as a human right to health.

---

Keywords :

Comorbidity, COVID-19, Mortality, SARS-CoV-2, Vaccination.

---

References :

1. Coronavirus disease 2019 (‎COVID-19)‎: situation report, 76 [Internet]. [cited 2022 Mar 30]. Available from: https://apps.who.int/iris/handle/10665/331689?search-result=true&query=76&scope=&rpp=10&sort_by=score&order=desc
2. Coronavirus disease 2019 (‎COVID-19)‎: situation report, 52 [Internet]. [cited 2022 Mar 30]. Available from: https://apps.who.int/iris/handle/10665/331476
3. Coronavirus Disease (COVID-19) Situation Reports, 145[Internet]. [cited 2022 Mar 30]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
4. Department of Disease Control Thailand [Internet]. [cited 2022 Mar 30]. Available from: https://ddc.moph.go.th/viralpneumonia/eng/index.php
5. Promlek T, Thanunchai M, Phumisantiphong U, Hansirisathit T, Phuttanu C, Dongphooyao S, et al. Performance of colorimetric reverse transcription loop-mediated isothermal amplification as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand. Int J Infect Dis [Internet]. 2022 Mar 1 [cited 2022 Mar 30];116:133–7. Available from: http://www.ijidonline.com/article/S1201971221012522/fulltext
6. Department of Disease Control Thailand [Internet]. [cited 2022 Mar 30]. Available from: https://ddc.moph.go.th/vaccine-covid19/diaryPresentMonth/07/10/2021
7. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol [Internet]. 2020 Jul 1 [cited 2022 Mar 20];146(1):110–8. Available from: https://doi.org/10.1016/j.jaci.2020.04.006
8. Giri M, Puri A, Wang T, Guo S. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Sci Prog [Internet]. 2021 [cited 2022 Mar 20];104(1). Available from: https://pubmed.ncbi.nlm.nih.gov/33752530/
9. Ng WH, Tipih T, Makoah NA, Vermeulen JG, Goedhals D, Sempa JB, et al. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. MBio [Internet]. 2021 Jan 1 [cited 2022 Mar 21];12(1):1–12. Available from: https://pubmed.ncbi.nlm.nih.gov/33563817/
10. Krishnasamy N, Natarajan M, Ramachandran A, Thangaraj JWV, Etherajan T, Rengarajan J, et al. Clinical outcomes among asymptomatic or mildly symptomatic covid-19 patients in an isolation facility in Chennai, India. Am J Trop Med Hyg. 2021 Jan 6;104(1):85–90.
11. Kimball A, Hatfield K, Arons M, … AJ-… and MW, 2020 undefined. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. ncbi.nlm.nih.gov [Internet]. [cited 2022 Apr 3]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7119514/
12. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020 Mar 12;25(10).
13. Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021 Feb 1;54(1):12–6.
14. Sirijatuphat R, Suputtamongkol Y, Angkasekwinai N, Horthongkham N, Chayakulkeeree M, Rattanaumpawan P, et al. Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand’s university-based referral hospital. BMC Infect Dis [Internet]. 2021 Dec 1 [cited 2022 Mar 20];21(1):1–10. Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06081-z
15. Hu J, Wang Y. The Clinical Characteristics and Risk Factors of Severe COVID-19. Gerontology. 2021;67(3):255–66.
16. Asia, C, Parveen, M, Pereira, A, and Press B. “Shattered Dreams; Broken Hopes” The Impact ofCovid-19 Pandemic migrant Workers in Southeast Asia” [Internet]. [cited 2022 Apr 3]. Available from: https://rigeo.org/submit-a-menuscript/index.php/submission/article/view/4108/3176
17. Lao Cambodian M. NUMBER OF DOCUMENTED MIGRANT WORKERS (As of August 2021) NUMBER OF COVID-19 CASES AMONGST MIGRANTS. 2021;
18. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City. medRxiv [Internet]. 2020 Apr 11 [cited 2022 Mar 21];2020.04.08.20057794. Available from: https://www.medrxiv.org/content/10.1101/2020.04.08.20057794v1
19. Musharrat Noor F, Islam MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health [Internet]. 1234;45:1270–82. Available from: https://doi.org/10.1007/s10900-020-00920-x
20. Yek C, Warner S, Wiltz JL, Sun J, Adjei S, Mancera A, et al. Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021. Morb Mortal Wkly Rep [Internet]. 2022 Jan 7 [cited 2022 Apr 1];71(1):19. Available from: /pmc/articles/PMC8735560/
21. Kalligeros M, Shehadeh F, Mylona EK, Kaczynski M, Kalagara S, Atalla E, et al. Clinical Outcomes of Adult Patients Hospitalized with COVID-19 after Vaccination. Trop Med Infect Dis 2021, Vol 6, Page 175 [Internet]. 2021 Sep 26 [cited 2022 Mar 21];6(4):175. Available from: https://www.mdpi.com/2414-6366/6/4/175/htm
22. Muthukrishnan J, Vardhan V, Mangalesh S, Koley M, Shankar S, Yadav AK, et al. Vaccination status and COVID-19 related mortality: A hospital-based cross-sectional study. Med J Armed Forces India [Internet]. 2021 Jul 1 [cited 2022 Apr 1];77:S278–82. Available from: www.sciencedirect.com